Literature DB >> 22898905

Salt sensitivity and nondippers in chronic kidney disease.

Michio Fukuda1, Genjiro Kimura.   

Abstract

High salt-sensitivity and nondipper blood pressure (BP) rhythm are highly associated with each other, because both are caused by impaired renal sodium excretion capability. We proposed that nocturnal hypertension and resultant pressure natriuresis could compensate for daytime sodium retention. If so, high BP may continue until sodium is sufficiently excreted at night. In fact, it takes longer for the night-time BP to fall in patients with more severe renal dysfunction. The time appears to be an essential component of the nondipper BP rhythm and, therefore, we defined the duration as the dipping time. Also, renal function was the sole determinant of a nocturnal BP dip other than age, sex, or BMI. Furthermore, we reported that diuretic therapy or dietary salt restriction, which can prevent sodium retention, restored the circadian BP rhythm into a dipper pattern. Large-scale studies are needed to explore whether these interventions can decrease the risks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898905     DOI: 10.1007/s11906-012-0286-3

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  53 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

Review 3.  Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences.

Authors:  Eberhard Ritz; William M McClellan
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

4.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

5.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

6.  Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II.

Authors:  N K Hollenberg; T Moore; D Shoback; J Redgrave; S Rabinowe; G H Williams
Journal:  Am J Med       Date:  1986-09       Impact factor: 4.965

7.  The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension.

Authors:  T Kawasaki; C S Delea; F C Bartter; H Smith
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

8.  Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy.

Authors:  Michio Fukuda; Miwa Munemura; Takeshi Usami; Naoyuki Nakao; Oki Takeuchi; Yoshinobu Kamiya; Atsuhiro Yoshida; Genjiro Kimura
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

9.  Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study).

Authors:  Luis García-Ortiz; Manuel A Gómez-Marcos; Javier Martín-Moreiras; Luis J González-Elena; Jose I Recio-Rodriguez; Yolanda Castaño-Sánchez; Gonzalo Grandes; Carlos Martínez-Salgado
Journal:  Blood Press Monit       Date:  2009-08       Impact factor: 1.444

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

View more
  4 in total

1.  The fixed-dose combination of losartan/hydrochlorothiazide elicits potent blood pressure lowering during nighttime in obese hypertensive patients.

Authors:  Chikao Ibuki; Yoshihiko Seino; Toshiaki Otsuka; Kyoichi Mizuno
Journal:  J Clin Med Res       Date:  2013-12-13

2.  Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy.

Authors:  Yukako Isobe-Sasaki; Michio Fukuda; Yoshiaki Ogiyama; Ryo Sato; Toshiyuki Miura; Daisuke Fuwa; Masashi Mizuno; Tetsuhei Matsuoka; Hiroko Shibata; Hiroyuki Ito; Minamo Ono; Sumiko Abe-Dohmae; Ken Kiyono; Yoshiharu Yamamoto; Hiroyuki Kobori; Makoto Michikawa; Junichiro Hayano; Nobuyuki Ohte
Journal:  Physiol Rep       Date:  2017-06

3.  Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney disease.

Authors:  Daisuke Fuwa; Michio Fukuda; Yoshiaki Ogiyama; Ryo Sato; Masashi Mizuno; Toshiyuki Miura; Sumiko Abe-Dohmae; Makoto Michikawa; Hiroyuki Kobori; Nobuyuki Ohte
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-06-09       Impact factor: 1.636

4.  Association of a Disrupted Dipping Pattern of Blood Pressure with Progression of Renal Injury during the Development of Salt-Dependent Hypertension in Rats.

Authors:  Abu Sufiun; Asadur Rahman; Kazi Rafiq; Yoshihide Fujisawa; Daisuke Nakano; Hideki Kobara; Tsutomu Masaki; Akira Nishiyama
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.